Skip to content

Meet our team attending ASCO

Chris Appleby

Director of Oncology Services

Professor Chris Nutting

Medical Assurance Director • Professional Standards Regulatory Affairs and Patient Safety

Care that connects: experiences from patients and clinicians

patient support programs

Accelerate access. Extend adherence. Deliver value.  

Getting patients on treatment fast – and keeping them on it – is one of the greatest clinical and commercial challenges in oncology treatment. 

Whether you’re launching a new therapy, scaling market access across Europe, or supporting real-world evidence generation, Sciensus delivers the infrastructure and expertise to help you reach patients  where they are – and keep them supported and compliant.  

Leveraging over 30 years of clinical experience, deep therapeutic expertise, and personalised digital innovation, we help biopharma and healthcare systems bring oncology treatments to patients.  

Learn more

Sciensus will be attending the upcoming ASCO (American Society of Clinical Oncology) 

ASCO is one of the most influential events in oncology, bringing together global leaders in cancer research, clinical practice, and patient care to advance the future of oncology treatment. 

Join us in Chicago to discover your trusted European end-to-end partner for oncology and specialty medicines. 

Sciensus

About Sciensus

Sciensus is the UK’s leading provider of complex clinical care at home. For over 30 years, we have partnered with the NHS to deliver specialist medicines, clinical nursing and patient support to people living with cancer, rare diseases and complex long-term conditions – supporting more than 300,000 patients a year across 180+ NHS trusts.

Beyond the UK, Sciensus helps pharmaceutical and biotech companies reach patients across Europe, managing the regulatory, logistics and patient support complexity of launching medicines in multiple markets.

Learn more